Compare CRI & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRI | EVO |
|---|---|---|
| Founded | 1865 | 1993 |
| Country | United States | Germany |
| Employees | N/A | 4766 |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2002 | N/A |
| Metric | CRI | EVO |
|---|---|---|
| Price | $33.21 | $3.41 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $34.00 | $7.00 |
| AVG Volume (30 Days) | ★ 1.0M | 144.4K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.38% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.75 | N/A |
| Revenue | ★ $2,844,102,000.00 | N/A |
| Revenue This Year | $2.49 | N/A |
| Revenue Next Year | $0.21 | $7.13 |
| P/E Ratio | $56.24 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $23.38 | $2.84 |
| 52 Week High | $44.44 | $4.80 |
| Indicator | CRI | EVO |
|---|---|---|
| Relative Strength Index (RSI) | 35.74 | 45.57 |
| Support Level | $28.71 | $3.40 |
| Resistance Level | $33.53 | $3.78 |
| Average True Range (ATR) | 1.92 | 0.09 |
| MACD | -0.44 | -0.03 |
| Stochastic Oscillator | 5.63 | 22.97 |
Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.